Systemic use of corticosteroids in neurological disorders

Open access


Corticosteroids have been used for almost 60 years in medicine and their roles in patients have always been discussed by researchers and clinicians dedicated in the related field. Now they are still used in treatment of patients with neurological disorders. Usually Corticosteroids are used to decrease inflammations. In this review, we present five key indications, i.e., bacterial meningitis, myasthenia gravis, Bell’s palsy and giant cell (temporal) arteritis for the systemic use of corticosteroids in neurology based on a mix of prevalence, quality of evidence and impact on disease management.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1. Kobelt G Berg J Atherly D Hadjimichael O. Costs and quality of life in multiple sclerosis: A cross-sectional study in the United States. Neurology 2006;66:1696-702.

  • 2. Noseworthy JH Lucchinetti C Rodriguez M Weinshenker BG. Multiple sclerosis. N Engl J Med 2000;343:938-52.

  • 3. Filippini G Brusaferri F Sibley WA Citterio A Ciucci G Midgard R et al. Corticosteroids or ACTH for acute exacerbations in multiple sclerosis. Cochrane Database Syst Rev 2000;4:CD001331.

  • 4. Burton JM O’Connor PW Hohol M Beyene J. Oral versus intravenous steroids for treatment of relapses in multiple sclerosis. Cochrane Database Syst Rev 2012;12:CD006921.

  • 5. Beck RW Cleary PA Anderson MM Jr Keltner JL Shults WT Kaufman DI et al. A randomized controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group. N Engl J Med 1992;326:581-8.

  • 6. Bhatt SM Lauretano A Cabellos C Halpin C Levine RA Xu WZ et al. Progression of hearing loss in experimental pneumococcal meningitis: Correlation with cerebrospinal fluid cytochemistry. J Infect Dis 1993;167:675-83.

  • 7. Sáez-Llorens X Jafari HS Severien C Parras F Olsen KD Hansen EJ et al. Enhanced attenuation of meningeal inflammation and brain edema by concomitant administration of anti-CD18 monoclonalantibodies and dexamethasone in experimental Haemophilus meningitis. J Clin Invest 1991;88:2003-11.

  • 8. de Gans J van de Beek D European Dexamethasone in Adulthood Bacterial Meningitis Study Investigators. Dexamethasone in adults with bacterial meningitis. N Engl J Med 2002;347:1549-56.

  • 9. Scarborough M Gordon SB Whitty CJ French N Njalale Y Chitani A et al. Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa. N Engl J Med 2007;357:2441-50.

  • 10. Nguyen TH Tran TH Thwaites G Ly VC Dinh XS Ho Dang TN et al. Dexamethasone in Vietnamese adolescents and adults with bacterial meningitis. N Engl J Med 2007;357:2431-40.

  • 11. Brouwer MC McIntyre P Prasad K van de Beek D. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev 2013;6:CD004405.

  • 12. Mann JD Johns TR Campa JF. Long-term administration of corticosteroids in myasthenia gravis. Neurology 1976;26:729-40.

  • 13. Pascuzzi RM Coslett HB Johns TR. Long-term corticosteroid treatment of myasthenia gravis: Report of 116 patients. Ann Neurol 1984;15:291-8.

  • 14. Miller RG Milner-Brown HS Mirka A. Prednisone-induced worsening of neuromuscular function in myasthenia gravis. Neurology 1986;36:729-32.

  • 15. Seybold ME Drachman DB. Gradually increasing doses of prednisone in myasthenia gravis. Reducing the hazards of treatment. N Engl J Med 1974;290:81-4.

  • 16. Sullivan FM Swan IR Donnan PT Morrison JM Smith BH McKinstry B et al. Early treatment with prednisolone or acyclovir in Bell’s palsy. N Engl J Med 2007;357:1598-607.

  • 17. Engström M Berg T Stjernquist-Desatnik A Axelsson S Pitkäranta A Hultcrantz M et al. Prednisolone and valaciclovir in Bell’s palsy: A randomised double-blind placebo-controlled multicentre trial. Lancet Neurol 2008;7:993-1000.

Journal information
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 1581 841 44
PDF Downloads 664 333 40